- Country: Slovakia
- Summary: Anti-Infective Ii Description: the Subject of the Contract is the Supply of Drugs Called Anti-Infective Ii Divided into Two Parts for a Procurement Period of 36 Months. a Detailed Description of the Subject of the Contract Forms Part of the Tender...
- SKT Ref No: 128630339
- Deadline: 20 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 247030
- Notice Type: Tender
- Document Ref. No.: 16771 - MST
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Anti-infective II Description: The subject of the contract is the supply of drugs called Anti-infective II divided into two parts for a procurement period of 36 months. A detailed description of the subject of the contract forms part of the tender documents B.2 Description of the subject of the contract. Order type: Goods 4.1.3 Scope of procurement Estimated value Estimated value (BT-27-Procedure) (value): 247,030 Estimated value (BT-27-Procedure) (currency): Euro Main classification Classification type: Common procurement vocabulary Main CPV code: Latky destroying bacteria for system use Information on the additional classification of the subject of the contract Information on the additional classification of the subject of the contract Classification type: Common procurement dictionary Supplementary CPV code: Antifungals for system use 4.1.4 Information about the place of fulfillment Information about the place of fulfillment Lower territorial unit of the country: Bratislava region Country: Slovakia 4.2 Competition conditions 4.2.1 Method of publication of reasons for exclusion Method of publication of reasons for exclusion Form of publication of reasons for exclusion: Competition documents 4.3 Information about the procedure 4.3.1 Procedure Type of procedure: Public competition 4.4 Information about submitting bids for parts 4.4.1 Maximum number of parts Maximum number of parts for which one bidder can submit a bid(s): 2 Maximum number of parts assigned to one applicant: 25. Parts 5.1 Information about part 5.1.1 Part Name: Part 01 - Anidulafungin UΔel Description of part Reference number: 543/2025/VO/KB/01 Name: Part 01 - Anidulafungin Description: β’ Type of item: Human drug β’ Drug + concentration: Each vial contains 100 mg of anidulafungin. The reconstituted solution contains 3.33 mg/ml anidulafungin and the diluted solution contains 0.77 mg/ml anidulafunginβ’ ATC group: J02AX06β’ Pharmaceutical form: powder for infusion concentrateβ’ Required quantity: 650 packs ...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAnti-Infective Ii Description: the Subject of the Contract is the Supply of Drugs Called Anti-Infective Ii Divided into Two Parts for a Procurement Period of 36 Months. a Detailed Description of the Subject of the Contract Forms Part of the Tender... - Slovakia Tender
The NATIONAL INSTITUTE OF HEART AND VASCULAR DISEASES, A.S., a Government sector organization in Slovakia, has announced a new tender for Anti-Infective Ii Description: the Subject of the Contract is the Supply of Drugs Called Anti-Infective Ii Divided into Two Parts for a Procurement Period of 36 Months. a Detailed Description of the Subject of the Contract Forms Part of the Tender.... This tender is published on SlovakiaTenders under SKT Ref No: 128630339 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-20.
The estimated tender value is EUR 247030, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
